Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:37:34 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:OPK - OPKO HEALTH INC - https://www.opko.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
OPK - Q0.61.22·1.260.61.24+0.010.83,382.14,0573,4151.24  1.25  1.232.035  1.1119:41:09Feb 0415 min RT 2¢

Recent Trades - Last 10 of 3415
Time ETExPriceChangeVolume
19:41:09Q1.250.021,000
19:40:36Q1.24990.0199500
19:40:11Q1.250.02200
19:40:03Q1.24970.0197830
19:23:39Q1.24010.01011
19:19:49Q1.240.011
19:05:31Q1.24980.019815
18:59:20Q1.240.011
18:52:14Q1.240.011
18:52:11Q1.250.0216

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-04 08:00U:OPKNews ReleaseOPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
2026-01-06 16:12U:OPKNews ReleaseOPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-11-19 16:05U:OPKNews ReleaseOPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
2025-11-13 08:03U:OPKNews ReleaseNextPlat Reports Third Quarter 2025 Results
2025-10-29 16:05U:OPKNews ReleaseOPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
2025-10-29 08:00U:OPKNews ReleaseOPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
2025-10-28 08:00U:OPKNews ReleaseOPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
2025-10-22 16:05U:OPKNews ReleaseOPKO Health to Report Third Quarter 2025 Financial Results on October 29
2025-09-15 08:30U:OPKNews ReleaseLabcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
2025-07-31 16:05U:OPKNews ReleaseOPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
2025-07-24 16:05U:OPKNews ReleaseOPKO Health to Report Second Quarter 2025 Financial Results on July 31
2025-07-08 08:00U:OPKNews ReleaseOPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
2025-06-25 11:00U:OPKNews ReleaseOPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
2025-06-25 08:00U:OPKNews ReleaseOPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
2025-06-09 08:00U:OPKNews ReleaseOPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
2025-05-15 08:00U:OPKNews ReleaseOPKO Health to Participate in Two Upcoming Investor Conferences
2025-04-30 16:05U:OPKNews ReleaseOPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
2025-04-17 08:00U:OPKNews ReleaseOPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025